substance p has been researched along with yttrium radioisotopes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apostolidis, C; Arnold, M; Cordier, D; Ghaffari, A; Good, S; Hofer, S; Ionescu, MC; Kneifel, S; Kretzschmar, M; Maecke, HR; Merlo, A; Mueller-Brand, J; Reubi, JC; Tolnay, M; Waser, B | 1 |
Bernhardt, P; Buitrago-Téllez, C; Good, S; Kneifel, S; Mäcke, H; Merlo, A; Müller-Brand, J; Plasswilm, L; Uusijärvi, H | 1 |
2 other study(ies) available for substance p and yttrium radioisotopes
Article | Year |
---|---|
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p.
Topics: Adult; Aged; Antineoplastic Agents; Base Sequence; Cell Line, Tumor; DNA Primers; Female; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Polymerase Chain Reaction; Radiopharmaceuticals; Restriction Mapping; Substance P; Yttrium Radioisotopes | 2006 |
Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas.
Topics: Adult; Aged; Antigens, Neoplasm; Brain; Brain Neoplasms; Cell Adhesion Molecules; Epithelial Cell Adhesion Molecule; Female; Glioma; Humans; Ligands; Male; Middle Aged; Models, Statistical; Models, Theoretical; Radiometry; Radiotherapy; Regression Analysis; Substance P; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2007 |